Exelixis Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2020-01-03 was 231.80K shares, a 39.50% decline year-over-year.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-09-27 was 894.77K shares, a 4.99% decline year-over-year.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-06-28 was 733.66K shares, a 14.04% decline year-over-year.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-03-29 was 1.41M shares, a 390.56% increase year-over-year.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 2.11M shares, a 30.91% decline from fiscal 2025.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 3.05M shares, a 30.38% increase from fiscal 2023.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 2.34M shares, a 14.69% decline from fiscal 2022.
- Exelixis Inc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 2.74M shares, a 38.85% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-01-02 | 2.11M shares 10-K · filed 2026-02-10 | |
| 2025-01-03 | 3.05M shares 10-K · filed 2025-02-11 | |
| 2023-12-29 | 2.34M shares 10-K · filed 2024-02-06 | |
| 2022-12-30 | 2.74M shares 10-K · filed 2023-02-07 | |
| 2021-12-31 | 4.49M shares 10-K · filed 2022-02-18 | |
| 2021-01-01 | 5.63M shares 10-K · filed 2021-02-11 | |
| 2020-01-03 | 231.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 3.27M shares 10-K · filed 2020-02-25 |
| 2019-09-27 | 894.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | 3.43M shares derived: sum of 4 quarters · filed 2019-10-30 |
| 2019-06-28 | 733.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | 3.47M shares derived: sum of 4 quarters · filed 2019-07-31 |
| 2019-03-29 | 1.41M shares 10-Q · filed 2019-05-01 | 3.59M shares derived: sum of 4 quarters · filed 2019-05-01 |
| 2018-12-28 | 383.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 2.47M shares 10-K · filed 2019-02-22 |
| 2018-09-28 | 941.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 2.27M shares derived: sum of 4 quarters · filed 2018-11-01 |
| 2018-06-29 | 853.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 2.37M shares derived: sum of 4 quarters · filed 2018-08-01 |
| 2018-03-30 | 288.20K shares 10-Q · filed 2018-05-02 | 2.46M shares derived: sum of 4 quarters · filed 2018-05-02 |
| 2017-12-29 | 186.36K shares derived: 10-K 12 month − 3 quarters · filed 2018-02-26 | 4.47M shares 10-K · filed 2018-02-26 |
| 2017-09-30 | 1.04M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | 7.16M shares derived: sum of 4 quarters · filed 2017-11-01 |
| 2017-06-30 | 944.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | 8.16M shares derived: sum of 4 quarters · filed 2017-08-02 |
| 2017-03-31 | 2.30M shares 10-Q · filed 2017-05-01 | 8.51M shares derived: sum of 4 quarters · filed 2017-05-01 |
| 2016-12-31 | 2.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | 6.24M shares 10-K · filed 2017-02-27 |
| 2016-09-30 | 2.04M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 4.83M shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 1.30M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | |
| 2016-03-31 | 21.50K shares 10-Q · filed 2016-05-04 | |
| 2015-12-31 | 1.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | 2.34M shares 10-K · filed 2016-02-29 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 19.09K shares 10-K · filed 2015-03-02 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | 27.93K shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | 28.52K shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-03-31 | 19.09K shares 10-Q · filed 2014-05-01 | 28.84K shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-12-31 | 8.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 13.31K shares 10-K · filed 2015-03-02 |
| 2013-09-30 | 589.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | 10.74K shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | 318.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | 122.75K shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | 3.57K shares 10-Q · filed 2013-05-07 | 163.51K shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | 6.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 181.98K shares 10-K · filed 2015-03-02 |
| 2012-09-30 | 112.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | |
| 2012-06-30 | 41.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | |
| 2012-03-31 | 22.03K shares 10-Q · filed 2012-05-03 | |
| 2011-12-31 | 2.16M shares 10-K · filed 2014-02-20 | |
| 2010-12-31 | 495.10K shares 10-K · filed 2013-02-21 | |
| 2009-12-31 | 59.76K shares 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |